Your session is about to expire
← Back to Search
Fractionated Stereotactic Radiation Therapy for Brain Cancer
Study Summary
This trial is testing a new way to give radiation for brain cancer. They want to see if it is safe and what the best dose is.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- You are able to perform daily activities without much difficulty.You can have more than one tumor, but only the main tumor will be treated for this study. Any other tumors may also be treated, but won't be part of the study's main goals.You have brain tumors caused by certain types of cancer.You are expected to live for more than 3 months.You cannot have metal implants that are not safe for MRI scans. If you have MRI-safe implants, you can still participate.You have brain metastases that have been confirmed with a recent MRI using contrast dye. If your diagnosis was done with a CT scan instead of an MRI, you can't participate.You have a serious health condition that is not being managed well, like heart problems or seizures.You have not had surgery to remove a specific brain lesion that is between 3 and 6 centimeters in size.You can join the study if you have received previous treatment for other lesions with stereotactic radiosurgery (SRS).You have received radiation therapy for the specific areas of concern in the past.You have been diagnosed with leptomeningeal metastases based on a cerebrospinal fluid examination.You are planning to receive chemotherapy or targeted therapy during the study. However, you can continue any hormonal therapy or bone support therapy you are currently receiving.You have been diagnosed with a non-blood-related cancer, except for small cell lung cancer, within the past 5 years.
- Group 1: Fractionated Stereotactic Radiation Therapy
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Has Fractionated Stereotactic Radiation Therapy attained regulatory approval?
"Our internal assessment of Fractionated Stereotactic Radiation Therapy's safety is rated 1, as the current Phase 1 trial has yet to provide ample evidence for efficacy and security."
Are there any remaining opportunities for participants to join this research?
"This research study, which was initially listed on December 25th 2017, is still seeking participants. The clinicaltrials.gov entry has been recently refreshed on May 4th 2022."
How many individuals are receiving the benefits of this clinical investigation?
"Affirmative. According to clinicaltrials.gov, this medical experiment is actively recruiting patients who first posted the trial on December 25th 2017 and recently updated it in May 4th 2022. 43 individuals are needed between a single location for participation."
Share this study with friends
Copy Link
Messenger